Delivery Order SPE2DE24DA017-SPE2D626F07D3
- Not listed
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, has been awarded a delivery order valued at $15,432.56 by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The order is structured as a fixed-price contract with economic price adjustment and carries an ultimate completion date of October 24, 2025. This delivery order operates under Arthrex's existing single-award Indefinite Delivery...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $17,155.73 by the Defense Logistics Agency's Medical Supply Chain on December 9, 2025, with an ultimate completion date of December 12, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, reflecting Arthrex's established competitive position as a primary federal supplier. The award is issued under Arthrex's...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $3,246.07 on May 20, 2025, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment is scheduled for completion by May 28, 2025, and represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $56,896.19 on September 8, 2025, with completion targeted for September 22, 2025. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The award carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal...
- Arthrex Inc., a leading global manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, has been awarded a delivery order valued at $1,100.88 by the Defense Logistics Agency's Medical Supply Chain for orthopedic surgical products. The award, issued on December 11, 2025, with an ultimate completion date of December 18, 2025, utilizes a fixed-price contract type with economic price adjustment provisions. This delivery order is issued without set-aside...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $5,557.20 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025. This fixed-price contract with economic price adjustment provisions is designated as a System Implementation Quadrilateral 9MM 1S and will be performed in Naples, Florida, with an ultimate completion date of August 21, 2025. The award is not set aside for any specific business...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a fixed-price delivery order valued at $72,555.97 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, with an ultimate completion date of August 15, 2025. This delivery order, designated as 4569067580, is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and running...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $20,083.00 by the Defense Logistics Agency's Medical Supply Chain on July 15, 2025. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by July 18, 2025, and represents a task order issued under Arthrex's larger Indefinite Delivery Contract (IDC) SPE2DE24D0020 with the Defense Logistics Agency, valued at...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $21,896 by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of October 7, 2025. This fixed-price delivery order with economic price adjustment falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, which is valued at $471 million and extends through September...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $156,060.97 by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of August 27, 2025. This fixed-price delivery order with economic price adjustment was issued under Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020), a single-award vehicle valued at $471 million and running through September 1, 2029. The...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F07D3Delivery Order
Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical devices and surgical solutions headquartered in Naples, Florida, has been awarded a delivery order valued at $55,810.83 for a targeting module under a fixed-price contract with economic price adjustment provisions. The award, issued on December 10, 2025, with an ultimate completion date of December 15, 2025, carries no set-aside designation, reflecting Arthrex's competitive position in federal procurement. The company will perform work at its Naples, FL facility under funding from the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for medical equipment procurement supporting Department of Defense and Department of Veterans Affairs healthcare operations. This delivery order is issued under Arthrex's existing Indefinite Delivery Contract SPE2DE24D0020 with the Defense Logistics Agency's Medical Supply Chain, a comprehensive master agreement valued at $471 billion and effective through September 1, 2029. The IDC authorizes procurement of a full spectrum of orthopedic products and surgical technologies, including surgical implants, arthroscopic instruments, joint replacement systems, and biologic products supporting VA medical centers and military healthcare facilities nationwide. Arthrex serves as the prime contractor on this award with no identified subcontractors, demonstrating the company's direct relationship with federal agencies and capacity to fulfill government orthopedic requirements independently across multiple surgical specialties.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.8k | 12/9/25 |